<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03491228</url>
  </required_header>
  <id_info>
    <org_study_id>A6831007</org_study_id>
    <nct_id>NCT03491228</nct_id>
  </id_info>
  <brief_title>Anaemetro I.V. Infusion 500mg Drug Use Investigation</brief_title>
  <official_title>Anaemetro Intravenous Infusion 500mg Drug Use Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Secondary Data Collection Study; safety and effectiveness of Anaemetro under Japanese medical
      practice
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2015</start_date>
  <completion_date type="Actual">August 22, 2017</completion_date>
  <primary_completion_date type="Actual">August 22, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with Adverse Events (AEs) by Seriousness and Relationship to Treatment</measure>
    <time_frame>Maximum 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Clinical Effectiveness</measure>
    <time_frame>Maximum 8 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">107</enrollment>
  <condition>Anaerobic Infection</condition>
  <condition>Infectious Enterocolitis</condition>
  <condition>Amebic Dysentery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who satisfy all of the inclusion criteria are subject to this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have not used metronidazole (injection) in the past, and have been given
             this drug for treatment of anaerobic infection, infectious enterocolitis, or amebic
             dysentery. Patients who have used metronidazole (oral agent and vaginal tablet) in the
             past are eligible, and should not be excluded from this study.

        Exclusion Criteria:

          -  No exclusion criteria are set out in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>April 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2018</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Dysentery</mesh_term>
    <mesh_term>Dysentery, Amebic</mesh_term>
    <mesh_term>Amebiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

